A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection
The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products
The main goal of the protocol, the research project plan, is to examine the scientific evidence on the effects of e-cigarettes on smokers from the available studies. The project includes writing a paper for doctors and health care providers, a fact sheet for people who use e-cigarettes, and a policy brief for legislators on health committees
A significant new three-year independent study on COPD and smoking has been released by the CoEHAR of the University of Catania (Italy), led by Professor Riccardo Polosa
A new study in Nicotine & Tobacco Research, published by Oxford University Press, finds that the use of high-strength nicotine e-cigarettes can help adults with schizophrenia spectrum disorders quit smoking
According to the latest study by COEHAR laboratories within the University of Catania, conducted by a group coordinated by Professor Riccardo Polosa, the risk of Covid-19 transmission with vaping is negligible, equal to 1%
"Vaping and COVID19: What are some of the key scientific learnings for public health and vaping as we prepare for 2021? What can we do better from patients’ perspectives?" the title of the event of last 16th December, where some of the most important names in the field of Harm Reduction discussed different topics, including the Public Health Response to the Covid-19 pandemic
The e-cigarette aerosol foster the transmission of the SARS-CoV-2 virus? According to the research, vaping add 1% risk to the already existing risks from breathing indoor
Vaping has revealed effective where official therapies failed. What is the secret of its success? A study by researchers Di Piazza, Caponnetto, Askin, Christos, Maglia, Gautam, Roche and Polosa tries to explain the reasons behind its success. The results are on the prestigious international Harm Reduction Journal.
Reflecting on the 15th Year of the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC), two international expert panel sessions featuring leading academics, researchers and NGO principals will cover the key questions and challenges facing policymakers in achieving more effective and equitable implementation globally
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.